Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT01165112. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant
ClinicalTrials.gov study NCT01431209. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT04052997. IPD Sharing: NO. Countries: 11. Publications: 1.
Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma
ClinicalTrials.gov study NCT01578967. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02783300. IPD Sharing: YES. Countries: 4. Publications: 0.
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Tri
ClinicalTrials.gov study NCT03233204. IPD Sharing: UNDECIDED. Countries: 2. Publications: 2.
Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene Mutation
ClinicalTrials.gov study NCT03456726. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eli
ClinicalTrials.gov study NCT01321541. IPD Sharing: Not stated. Countries: 17. Publications: 2.
Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
ClinicalTrials.gov study NCT00103610. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00302003. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT02572167. IPD Sharing: Not stated. Countries: 1. Publications: 2.
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00006721. IPD Sharing: YES. Countries: 1. Publications: 3.
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00278408. IPD Sharing: Not stated. Countries: 4. Publications: 1.
To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL)
ClinicalTrials.gov study NCT04661007. IPD Sharing: YES. Countries: 1. Publications: 1.
Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00119392. IPD Sharing: Not stated. Countries: 1. Publications: 2.
10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00052442. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00278161. IPD Sharing: NO. Countries: 1. Publications: 1.
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00989586. IPD Sharing: NO. Countries: 1. Publications: 1.
Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00765245. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma
ClinicalTrials.gov study NCT00848926. IPD Sharing: Not stated. Countries: 5. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.